추천 논문

제목Antibody Structure and Function: The Basis for Engineering Therapeutics2023-09-15 20:37
작성자 Level 8

Antibody Structure and Function: The Basis for Engineering Therapeutics

https://www.mdpi.com/2073-4468/8/4/55


first_pagesettingsOrder Article Reprints

Open AccessReview

Antibody Structure and Function: The Basis for Engineering Therapeutics

by Mark L. Chiu 1,*ORCID,Dennis R. Goulet 2ORCID,Alexey Teplyakov 3 andGary L. Gilliland 3

1

Drug Product Development Science, Janssen Research & Development, LLC, Malvern, PA 19355, USA

2

Department of Medicinal Chemistry, University of Washington, P.O. Box 357610, Seattle, WA 98195-7610, USA

3

Biologics Research, Janssen Research & Development, LLC, Spring House, PA 19477, USA

*

Author to whom correspondence should be addressed.

Antibodies 2019, 8(4), 55; https://doi.org/10.3390/antib8040055

Received: 16 October 2019 / Revised: 25 November 2019 / Accepted: 28 November 2019 / Published: 3 December 2019

(This article belongs to the Special Issue Structure and Function of Antibodies)

Download Browse Figures Versions Notes

Abstract

Antibodies and antibody-derived macromolecules have established themselves as the mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure–function relationships of antibodies provides a platform for protein engineering that has been exploited to generate a wide range of biologics for a host of therapeutic indications. In this review, our basic understanding of the antibody structure is described along with how that knowledge has leveraged the engineering of antibody and antibody-related therapeutics having the appropriate antigen affinity, effector function, and biophysical properties. The platforms examined include the development of antibodies, antibody fragments, bispecific antibody, and antibody fusion products, whose efficacy and manufacturability can be improved via humanization, affinity modulation, and stability enhancement. We also review the design and selection of binding arms, and avidity modulation. Different strategies of preparing bispecific and multispecific molecules for an array of therapeutic applications are included.

Keywords: antibody engineering; therapeutic biologics

댓글
자동등록방지
(자동등록방지 숫자를 입력해 주세요)

Antibody, Microbiome, Mitochondria, Nanobodies, Protein engineering, Identification of Bacteria, Systems Biology, Structural biology,


Nanobodies

A comprehensive comparison between camelid nanobodies and single chain variable fragments

https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00332-6

The Therapeutic Potential of Nanobodies

https://link.springer.com/article/10.1007/s40259-019-00392-z

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19

https://www.nature.com/articles/s41467-021-25480-z

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike

https://www.science.org/doi/10.1126/science.abe3255

Antibody

Antibodies to combat viral infections: development strategies and progress

https://www.nature.com/articles/s41573-022-00495-3

Microbiome

Gut microbiota in human metabolic health and disease

https://www.nature.com/articles/s41579-020-0433-9

Current understanding of the human microbiome

https://www.nature.com/articles/nm.4517

A framework for microbiome science in public health

https://www.nature.com/articles/s41591-021-01258-0

Mitochondria

Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes

https://www.nature.com/articles/s41586-022-05288-7

Protein engineering

Advances in protein structure prediction and design

https://www.nature.com/articles/s41580-019-0163-x

https://www.nature.com/subjects/protein-engineering

Identification of Bacteria

16S rRNA 유전자 염기서열분석을 통한 임상 미생물학에서의 세균동정

https://kosen.kr/info/kosen/273696

16S rRNA 및 Internal Transcribed Spacer 염기서열 분석법을 이용한 세균 및 진균 동정

https://synapse.koreamed.org/upload/synapsedata/pdfdata/0105kjcm/kjcm-13-34.pdf